The Risk of Cancer in Users of Statins

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

1996 • 7,450 citations

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

1995 • 7,378 citations

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels

1998 • 5,293 citations

Regulation of the mevalonate pathway

1990 • 5,282 citations

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1998 • 5,229 citations

ras oncogenes in human cancer: a review.

1989 • 5,116 citations

PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

1995 • 3,524 citations

Statins and the risk of dementia

2000 • 1,741 citations

Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors

2000 • 1,415 citations

A chronic disease score from automated pharmacy data

1992 • 960 citations

Blocking Oncogenic Ras Signaling for Cancer Therapy

2001 • 837 citations

Validation of pharmacy records in drug exposure assessment

1997 • 378 citations

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

1996 • 368 citations

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

2001 • 354 citations

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors and the Risk of Cancer

2000 • 320 citations

Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering

2000 • 279 citations

Incidence of Cancer in the Netherlands 1998

2002 • 262 citations

Cholesterol and Alzheimer’s disease

2001 • 258 citations

Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types

1997 • 218 citations

Increased Sensitivity of Acute Myeloid Leukemias to Lovastatin-Induced Apoptosis: A Potential Therapeutic Approach

1999 • 206 citations

Do statins cause cancer? A meta-analysis of large randomized clinical trials

2001 • 194 citations

Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.

2001 • 164 citations

Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis

1998 • 147 citations

Incidence of Cancer

1934 • 118 citations

Inhibition of pancreatic adenocarcinoma cell growth by lovastatin

1992 • 109 citations

Lovastatin Induces Apoptosis in Malignant Mesothelioma Cells

1998 • 104 citations

Lovastatin-induced apoptosis of human medulloblastoma cell lines in vitro.

1999 • 78 citations

Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2)

1994 • 64 citations

Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin

2000 • 37 citations

Apoptosis of medulloblastoma cellsIn vitro follows inhibition of farnesylation using manumycin A

1999 • 37 citations

Hydroxymethylglutaryl-Coenzyme A Reductase Inhibitors in Osteoporosis Management

2002 • 25 citations

ras p21 isoprenylation inhibition induces flat colon tumors in Wistar rats

2000 • 17 citations